{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:09:48Z","timestamp":1787004588198,"version":"build-2736575974"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2775,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2000,12]]},"abstract":"<jats:p>\n                    <jats:bold>Background.<\/jats:bold>\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    colonization and associated inflammation are influenced by local acid output. Infected subjects with acid\u2010related diseases, such as gastroesophageal reflux disease (GERD) are likely to have an antral\u2010predominant gastritis. We hypothesized that long\u2010term acid suppression would result in relatively greater bacterial colonization in the corpus leading to diffuse or corpus\u2010predominant gastritis and that this would be prevented by prior\n                    <jats:italic>H. pylori<\/jats:italic>\n                    eradication.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and Methods.<\/jats:bold>\n                    To investigate this, we conducted a prospective, double\u2010blind trial of the effect on gastric histology of 12\u2010month maintenance treatment with omeprazole in\n                    <jats:italic>H. pylori<\/jats:italic>\n                    \u2013positive GERD patients randomly assigned to either an eradication or omeprazole\u2010alone regime. A control group of 20\n                    <jats:italic>H. pylori<\/jats:italic>\n                    \u2013negative GERD patients also received omeprazole throughout the study period. Biopsies taken at baseline and at 12 months were graded \u201cblind\u201d by a single observer according to the updated Sydney System. The 41\n                    <jats:italic>H. pylori<\/jats:italic>\n                    \u2010positive subjects with grade B or C esophagitis were randomly assigned (20 to omeprazole alone, 21 to eradication) and 33 subjects completed the 12\u2010month study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    There was a significant decline in antral chronic inflammation in initially positive patients between baseline and end in both the eradication group (\n                    <jats:italic>p<\/jats:italic>\n                    = .035) and the omeprazole\u2010alone group (\n                    <jats:italic>p<\/jats:italic>\n                    = .008). However, corpus chronic inflammation increased in the omeprazole\u2010alone group (\n                    <jats:italic>p<\/jats:italic>\n                    = .0156) but decreased in the eradication group. The change toward corpus predominance between baseline and end for the omeprazole\u2010alone group is highly significant (\n                    <jats:italic>p<\/jats:italic>\n                    = .0078). Furthermore, 5 of 11 in the omeprazole\u2010alone group developed mild corpus atrophy, compared to 0 of 8 who had undergone\n                    <jats:italic>H. pylori<\/jats:italic>\n                    eradication. The change in frequency of corpus atrophy between the two groups is significant (\n                    <jats:italic>p<\/jats:italic>\n                    = .02).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion.<\/jats:bold>\n                    In\n                    <jats:italic>H. pylori<\/jats:italic>\n                    \u2013positive subjects with GERD, long\u2010term acid suppression leads to a shift from antral\u2010 to corpus\u2010predominant gastritis that can be prevented by prior eradication. The shift is accompanied by an increase in corpus atrophy.\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection should be eradicated prior to long\u2010term acid suppression with proton pump inhibitors.\n                  <\/jats:p>","DOI":"10.1046\/j.1523-5378.2000.00032.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T18:22:12Z","timestamp":1047406932000},"page":"206-214","source":"Crossref","is-referenced-by-count":97,"title":["Changing Patterns of\n                    <i>Helicobacter pylori<\/i>\n                    Gastritis in Long\u2010Standing Acid Suppression"],"prefix":"10.1111","volume":"5","author":[{"given":"Paul","family":"Moayyedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Wason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Walan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karna","family":"Bardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T. R.","family":"Axon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1991.tb01451.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92808-7"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8698230"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199610000-00001"},{"key":"e_1_2_6_6_2","volume-title":"Biopsy Pathology of the Oesophagus, Stomach and Duodenum","author":"Day DW","year":"1995"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.1.12"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409105357"},{"key":"e_1_2_6_9_2","first-page":"1401","article-title":"Increase of Helicobacter pylori\u2013associated corpus gastritis during acid suppressive therapy: Implications for long\u2010term safety.","volume":"90","author":"Kuipers EJ","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90686-X"},{"key":"e_1_2_6_11_2","first-page":"867","article-title":"Antral and body Helicobacter pylori status after short\u2010 and long\u2010term omeprazole monotherapy.","volume":"4","author":"Cariani G","year":"1992","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_12_2","first-page":"147A","article-title":"Omeprazole long\u2010term treatment for duodenal ulcer: effects on the gastric distribution of Helicobacter pylori.","volume":"56","author":"Vigneri S","year":"1993","journal-title":"Acta Gastroenterol Belg"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00310.x"},{"key":"e_1_2_6_14_2","first-page":"720","article-title":"Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole.","volume":"92","author":"Graham DY","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70142-8"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00196.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200921"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90344-C"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-3-199408010-00001"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00391.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341603"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9041231"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.6.740"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91084-0"},{"issue":"2","key":"e_1_2_6_25_2","first-page":"A67","article-title":"H. pylori colonization and development of multifocal atrophic gastritis in cats.","volume":"43","author":"Esteves MI","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409096832"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.5.619"},{"key":"e_1_2_6_28_2","first-page":"151","article-title":"H. pylori corpus gastritis\u2014relation to acid output.","volume":"47","author":"Sipponen P","year":"1996","journal-title":"J Physiol Pharmacol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/105.1.96"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528509089657"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1999.0029900319"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1999.00635.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910530114"},{"issue":"1","key":"e_1_2_6_34_2","first-page":"S59","article-title":"The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer.","volume":"7","author":"Sakaki N","year":"1995","journal-title":"Euro J Gastroenterol Hepatol"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80012-1"},{"key":"e_1_2_6_36_2","first-page":"229","article-title":"Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach.","volume":"28","author":"Stolte M","year":"1990","journal-title":"Z Gastroenterol"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.181"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004280050171"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1523-5378.2000.00032.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1523-5378.2000.00032.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1523-5378.2000.00032.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1523-5378.2000.00032.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:25:09Z","timestamp":1694417109000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1523-5378.2000.00032.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["10.1046\/j.1523-5378.2000.00032.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-5378.2000.00032.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}